Publications and communications of Michel Malaise

Guiot, J., Henket, M., Remacle, C., Cambier, M., Struman, I., Winandy, M.-L., Moermans, C., Louis, E., Malaise, M., Ribbens, C., Louis, R., & Njock, M.-S. (15 April 2023). Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis. Respiratory Research, 24 (1), 112. doi:10.1186/s12931-023-02413-6

Massenet, T., Guiot, J., Zanella, D., Dejong, T., GILTAY, L., Henket, M., GUISSARD, F., André, B., Malaise, M., Potjewijd Judith, Schleich, F., Louis, R., Focant, J.-F., & Stefanuto, P.-H. (29 March 2023). Etude métabolomique de l’air exhalé pour diagnostiquer la sclérodermie systémique par chromatographie gazeuse bidimensionnelle exhaustive [Paper presentation]. SEP 23, Paris, France.

Guiot, J., Henket, M., Ernst, M., Seidel, L., WINANDY, M.-L., DENIS, A., Frix, A.-N., GESTER, F., THYS, M., GILTAY, L., Garah, O., Njock, M.-S., CANIVET, P., Meunier, P., Corhay, J.-L., Regnier, C., Malaise, O., Malaise, M., & Louis, R. (09 March 2023). Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis. Frontiers in Medicine, 10. doi:10.3389/fmed.2023.1063012

DENIS, A., Henket, M., Ernst, M., Maes, N., THYS, M., Regnier, C., Malaise, O., Frix, A.-N., GESTER, F., DESIR, C., Meunier, P., Louis, R., Malaise, M., & Guiot, J. (30 November 2022). Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study. Frontiers in Medicine, 9. doi:10.3389/fmed.2022.1024298

Massenet, T., GUIOT, J., Zanella, D., Dejong, T., GILTAY, L., HENKET, M., GUISSARD, F., ANDRE, B., MALAISE, M., Judith Potjewijd, SCHLEICH, F., LOUIS, R., Focant, J.-F., & Stefanuto, P.-H. (18 May 2022). BREATHOMICS APPROACH TO INVESTIGATE SYSTEMIC SCLEROSIS USING THERMAL DESORPTION AND COMPREHENSIVE TWO-DIMENSIONAL GAS CHROMATOGRAPHY HIGH-RESOLUTION TIME-OF-FLIGHT MASS SPECTROMETRY [Poster presentation]. 17th International Symposium on Hyphenated Techniques in Chromatography and Separation Technology (HTC-17), Gand, Belgium.

Stefanuto, P.-H., Zanella, D., Dejong, T., Massenet, T., DiGiovanni, N., GILTAY, L., HENKET, M., GUISSARD, F., SCHLEICH, F., GUIOT, J., ANDRE, B., MALAISE, M., Potjewijd, J., MEUWIS, M.-A., LOUIS, E., & Focant, J.-F. (May 2022). Recent advances in medical applications of GC×GC [Paper presentation]. HTC-17, Ghent, Belgium.

Mina, M., Bolland, M., MALAISE, O., Pottier, L., POIRRIER, A.-L., TOMBU, S., & MALAISE, M. (21 March 2022). Les vascularites à ANCA chez les consommateurs de cocaïne : de la poudre aux yeux ? [Paper presentation]. GLEM ORL, Liege, Belgium.

Massenet, T., GUIOT, J., Zanella, D., Dejong, T., GILTAY, L., HENKET, M., GUISSARD, F., ANDRE, B., MALAISE, M., Potjewijd Judith, SCHLEICH, F., LOUIS, R., Focant, J.-F., & Stefanuto, P.-H. (01 February 2022). TD-GC×GC-HRTOFMS to investigate pulmonary fibrosis in patients [Poster presentation]. Multidimensional Chromatography Worshop 2022.

DEROYER, C., Poulet, C., PAULISSEN, G., Ciregia, F., MALAISE, O., PLENER, Z., COBRAIVILLE, G., DANIEL, C., GILLET, P., MALAISE, M., & DE SENY, D. (2022). CEMIP (KIAA1199) regulates inflammation, hyperplasia and fibrosis in osteoarthritis synovial membrane. Cellular and Molecular Life Sciences. doi:10.1007/s00018-022-04282-6

Horcajada, M.-N., Beaumont, M., Sauvageot, N., Poquet, L., Saboundjian, M., Costes, B., Verdonk, P., Brands, G., Brasseur, J., Urbin-Choffray, D., Vandenberghe, M., Brabants, K., De Vlam, K., Fache, W., Jandrain, B., Grek, V., MALAISE, M., & Henrotin, Y. (2022). An oleuropein-based dietary supplement may improve joint functional capacity in older people with high knee joint pain: findings from a multicentre-RCT and post hoc analysis. Therapeutic Advances in Musculoskeletal Disease, 14, 1759720X211070205. doi:10.1177/1759720X211070205

Jouret, M., RINKIN, C., SEGHAYE, M.-C., & MALAISE, M. (October 2021). À propos d’une cohorte de jeunes patients suivis dans le service de rhumatologie adulte du CHU de Liège. Revue Médicale de Liège, 76 (10), 741-745.

CIREGIA, F., Nys, G., Cobraiville, G., Badot, V., Di Romana, S., Sidiras, P., Sokolova, T., Durez, P., Fillet, M., Malaise, M., & de Seny, D. (2021). A Cross-Sectional and Longitudinal Study to Define Alarmins and A-SAA Variants as Companion Markers in Early Rheumatoid Arthritis. Frontiers in Immunology. doi:10.3389/fimmu.2021.638814

JACQUERIE, P., HENKET, M., André, B., MOERMANS, C., DE SENY, D., GESTER, F., LOUIS, R., MALAISE, M., & GUIOT, J. (21 May 2021). Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers. Scientific Reports, 11 (1), 10679. doi:10.1038/s41598-021-87701-1

Ciregia, F., DEROYER, C., COBRAIVILLE, G., PLENER, Z., MALAISE, O., GILLET, P., Fillet, M., MALAISE, M., & DE SENY, D. (2021). Modulation of αVβ6 integrin in osteoarthritis-related synovitis and the interaction with VTN (381-397 a.a.) competing for TGF-β1 activation. Experimental and Molecular Medicine. doi:10.1038/s12276-021-00558-2

CALMES, D., Graff, S., MAES, N., Frix, A.-N., THYS, M., BONHOMME, O., Berg, J., DEBRUCHE, M., GESTER, F., HENKET, M., PAULUS, V., DUYSINX, B., HEINEN, V., NGUYEN DANG, D., PAULUS, A., QUAEDVLIEG, V., VAILLANT, F., VAN CAUWENBERGE, H., MALAISE, M., ... SCHLEICH, F. (2021). Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection. Journal of Allergy and Clinical Immunology: In Practice, 9 (1), 160-169. doi:10.1016/j.jaip.2020.09.044

GUIOT, J., NJOCK, M.-S., ANDRE, B., GESTER, F., HENKET, M., DE SENY, D., MOERMANS, C., MALAISE, M., & LOUIS, R. (2021). Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction. Scientific Reports, 11 (1), 10882. doi:10.1038/s41598-021-90333-0

RELIC, B., DEROYER, C., MALAISE, O., Plener, Z., Gillet, P., de Seny, D., & Malaise, M. (2021). TFEB phosphorylation on Serine 211 is induced by autophagy in human synovial fibroblasts and by p62/SQSTM1 overexpression in HEK293 cells. Biochemical Journal, 478 (16), 3145-3155. doi:10.1042/BCJ20210174

Zanella, D., GUIOT, J., Stefanuto, P.-H., GILTAY, L., HENKET, M., GUISSARD, F., ANDRE, B., MALAISE, M., Potjewijd, J., SCHLEICH, F., LOUIS, R., & Focant, J.-F. (2021). TD-GC×GC-HRTOFMS for Breath Profiling of Systemic Sclerosis. In Proceedings.

GUIOT, J., Cambier, M., Boeckx, A., HENKET, M., Nivelles, O., GESTER, F., LOUIS, E., MALAISE, M., Dequiedt, F., LOUIS, R., Struman, I.* , & NJOCK, M.-S.*. (05 August 2020). Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p. Thorax, 75 (10), 870-881. doi:10.1136/thoraxjnl-2019-214077
* These authors have contributed equally to this work.

Poulet, C., NJOCK, M.-S., MOERMANS, C., LOUIS, E., LOUIS, R., MALAISE, M., & GUIOT, J. (01 May 2020). Exosomal Long Non-Coding RNAs in Lung Diseases. International Journal of Molecular Sciences, 21 (10), 3580. doi:10.3390/ijms21103580

de Seny, D., Bianchi, E., Baiwir, D., COBRAIVILLE, G., Collin, C., Deliège, M., Kaiser, M.-J., Mazzucchelli, G., Hauzeur, J.-P., Delvenne, P., & Malaise, M. (2020). Proteins involved in the endoplasmic reticulum stress are modulated in synovitis of osteoarthritis, chronic pyrophosphate arthropathy and rheumatoid arthritis, and correlate with the histological inflammatory score. Scientific Reports, 10 (1). doi:10.1038/s41598-020-70803-7

Gendebien, Z., VON FRENCKELL, C., RIBBENS, C., ANDRE, B., THYS, M., GANGOLF, M., SEIDEL, L., Malaise, M., & MALAISE, O. (2020). Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments. Annals of the Rheumatic Diseases. doi:10.1136/annrheumdis-2020-218244

Guiot, J., HENKET, M., André, B., Herzog, M., Hardat, N., NJOCK, M.-S., MOERMANS, C., Malaise, M., & Louis, R. (2020). A new nucleosomic-based model to identify and diagnose SSc-ILD. Clinical Epigenetics, 12 (1), 124. doi:10.1186/s13148-020-00915-4

HAUZEUR, J.-P., LECHANTEUR, C., BAUDOUX, E., De Maertelaer, V., Pather, S., Katz, R., Malaise, M., Ino, J., & Beguin, Y. (2020). Did Osteoblastic Cell Therapy Improve the Prognosis of Prefracture Osteonecrosis of the Femoral Head? A Randomized, Controlled Trial. Clinical Orthopaedics and Related Research, 478, 1307-1315.

Nys, G., COBRAIVILLE, G., Servais, A.-C., Malaise, M., DE SENY, D., & Fillet, M. (2019). Targeted proteomics reveals serum amyloid A variants and alarmins S100A8-S100A9 as key plasma biomarkers of rheumatoid arthritis. Talanta. doi:10.1016/j.talanta.2019.06.044

DEROYER, C., CHARLIER, E., NEUVILLE, S., MALAISE, O., GILLET, P., KURTH, W., Chariot, A., MALAISE, M., & DE SENY, D. (2019). CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes. Cell Death and Disease. doi:10.1038/s41419-019-1377-8

BONHOMME, O., ANDRE, B., GESTER, F., DE SENY, D., MOERMANS, C., Struman, I., Louis, R., MALAISE, M., & GUIOT, J. (2019). Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature. Rheumatology (Oxford, England). doi:10.1093/rheumatology/kez230

GUIOT, J., Struman, I., Louis, E., Louis, R., Malaise, M., & Njock, M.-S. (2019). Exosomal miRNAs in Lung Diseases: From Biologic Function to Therapeutic Targets. Journal of Clinical Medicine, 8 (9). doi:10.3390/jcm8091345

Henrotin, Y., Bannuru, R., Malaise, M., Ea, H.-K., Confavreux, C., Bentin, J., Urbin-Choffray, D., Conrozier, T., Brasseur, J.-P., Thomas, P., Hick, A.-C., Marinello, A., Giordan, N., & Richette, P. (2019). Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: Data from MOKHA study. BMC Musculoskeletal Disorders, 20 (1). doi:10.1186/s12891-019-2667-0

Henrotin, Y., Malaise, M., Wittoek, R., De Vlam, K., Brasseur, J.-P., Luyten, F. P., Jiangang, Q., Van Den Berghe, M., Uhoda, R., Bentin, J., De Vroey, T., Erpicum, L., Donneau, A.-F., & Dierckxsens, Y. (2019). Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: A double-blind multicenter randomized placebo controlled three-arm study. Arthritis Research and Therapy, 21 (1). doi:10.1186/s13075-019-1960-5

Henrotin, Y., Bannuru, R. R., Malaise, M., EA, K., Confavreux, C., Bentin, J., Urbin-Choffray, D., Conrozier, T., Brasseur, Thomas, T., Marrinello, A., Giordan, N., & Richette, P. (June 2018). HYALURONAN DERIVATIVE HYMOVIS® INCREASES CARTILAGE VOLUME AND TYPE II COLLAGEN TURNOVER IN OSTEOARHRITIC KNEE: DATA FROM MOKHA STUDY. Annals of the Rheumatic Diseases, 77 (supplement 2), 1614.

Henrotin, Y., Malaise, M., Wittoek, R., Devlam, K., Brasseur, J.-P., Luyten, F., Jiangang, Q., Van den Berghe, M., Uhoda, R., Bentin, J., De Vroey, T., Erpicum, L., & Dierckxsens, Y. (June 2018). EFFICACY OF BIO-OPTIMISED CURCUMA EXTRACT (FLEXOFYTOL®) FOR PAINFUL KNEE OSTEOARTHRITIS: DATA FROM COPRA, A MULTICENTER RANDOMISED CONTROLLED STUDY. Annals of the Rheumatic Diseases, 77 (supplement 2), 790.

HAUZEUR, J.-P., De Maertelaer, V., BAUDOUX, E., MALAISE, M., Beguin, Y., & Gangji, V. (2018). Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. International Orthopaedics, 42, 1429-1435. doi:10.1007/s00264-017-3650-8

RELIC, B., CHARLIER, A., DEROYER, C., MALAISE, O., Crine, Y., NEUVILLE, S., GILLET, P., DE SENY, D., & Malaise, M. (2018). Serum starvation raises turnover of phosphorylated p62/SQSTM1 (Serine 349), reveals expression of proteasome and N-glycanase1 interactive protein RAD23B and sensitizes human synovial fibroblasts to BAY 11-7085-induced cell death. Oncotarget, 9 (88), 35830-35843. doi:10.18632/oncotarget.26295

QUESADA-CALVO, F., MASSOT, C., Bertrand, V., Longuespée, R., BLETARD, N., SOMJA, J., Mazzucchelli, G., Smargiasso, N., Baiwir, D., De Pauw-Gillet, M.-C., Delvenne, P., MALAISE, M., COIMBRA MARQUES, C., POLUS, M., De Pauw, E., MEUWIS, M.-A., & Louis, E. (24 March 2017). OLFM4, KNG1 and Sec24C identified by proteomics and immunohistochemistry as potential markers of early colorectal cancer stages. Clinical Proteomics, 24 (9). doi:10.1186/s12014-017-9143-3

CHARLIER, E., RELIC, B., Deroyer, C., MALAISE, O., NEUVILLE, S., Collée, J., MALAISE, M., & DE SENY, D. (2016). Insights on Molecular Mechanisms of Chondrocytes Death in Osteoarthritis. International Journal of Molecular Sciences. doi:10.3390/ijms17122146

DE SENY, D., COBRAIVILLE, G., Leprince, P., Fillet, M., Collin, C., Mathieu, M., HAUZEUR, J.-P., Gangji, V., & Malaise, M. (2016). Biomarkers of inflammation and innate immunity in atrophic nonunion fracture. Journal of Translational Medicine. doi:10.1186/s12967-016-1019-1

HAUZEUR, J.-P., Malaise, M., & de MARTELAER, V. (2016). A prospective cohort study of the clinical presentation of non-traumatic osteonecrosis of the femoral head: spine and knee symptoms as clinical presentation of hip osteonecrosis. International Orthopaedics. doi:10.1007/s00264-015-3079-x

Baiwir, D., Mazzucchelli, G., Smargiasso, N., QUESADA CALVO, F., De Pauw, E., MALAISE, M., Louis, E., & MEUWIS, M.-A. (December 2015). Comparison of serum fractionation methods by data independent label-free proteomics. EuPA Open Proteomics, 9, 14-22. doi:10.1016/j.euprot.2015.07.009

DE SENY, D., COBRAIVILLE, G., CHARLIER, E., NEUVILLE, S., LUTTERI, L., LE GOFF, C., MALAISE, D., MALAISE, O., CHAPELLE, J.-P., RELIC, B., & MALAISE, M. (2015). Apolipoprotein-A1 as a damage-associated molecular patterns protein in osteoarthritis: ex vivo and in vitro pro-inflammatory properties. PLoS ONE. doi:10.1371/journal.pone.0122904

MUTIJIMA NZARAMBA, E., De Maertelaer, V., Deprez, M., Malaise, M., & HAUZEUR, J.-P. (December 2014). The apoptosis of osteoblasts and osteocytes in femoral head osteonecrosis: its specificity and its distribution. Clinical Rheumatology, 33 (12), 1791-5. doi:10.1007/s10067-014-2607-1

ZEDDOU M, RELIC, B., & Malaise, M. (2014). Umbilical cord fibroblasts. Rheumatology.

MEUWIS, M.-A., Baiwir, D., Mazzucchelli, G., Smargiasso, N., Quesada-Calvo, F., MALAISE, M., De Pauw, E., The GETAID, & LOUIS, E. (06 October 2014). Potential Proteomic Biomarkers Associated To Mucosal Healing In Crohn’s Disease [Poster presentation]. HUPO2014, Madrid, Spain.

MALAISE, O., VON FRENCKELL, C., ANDRE, B., & Malaise, M. (28 August 2013). The management of systemic lupus erythematosus with biological therapies. Revue Médicale Suisse, 9 (395), 1507-11.

RINKIN, C., VAN DURME, C., FAUTREL, B., & Malaise, M. (July 2013). Un cas rare d’arthrite fébrile. Revue Médicale de Liège, 68 (7-8), 423-7.

MALAISE, O., VON FRENCKELL, C., & Malaise, M. (May 2012). Genetic and environmental interactions on the development of rheumatoid arthritis. Revue Médicale de Liège, 67 (5-6), 305-13.

MALAISE, O., MALAISE, M., & Simoni, P. (April 2012). L'image du mois. Goutte tophacée floride de l'avant-pied. Revue Médicale de Liège, 67 (4), 165-6.

VON FRENCKELL, C., & Malaise, M. (2012). Targeted therapy in inflammatory disease: cytokines. Revue Médicale de Liège, 67 (22-8).

Zeddou, M., RELIC, B., MALAISE, O., CHARLIER, E., Desouroux, A., BEGUIN, Y., DE SENY, D., & Malaise, M. (2012). Differential signalling through ALK-1 and ALK-5 regulates leptin expression in Mesenchymal Stem Cells. Stem Cells and Development, 21 (11), 1948-54. doi:10.1089/scd.2011.0321

DE SENY, D., Sharif, M., Fillet, M., COBRAIVILLE, G., Meuwis, M.-A., Marée, R., HAUZEUR, J.-P., Wehenkel, L., Louis, E., Merville, M.-P., Kirwan, J., Ribbens, C., & Malaise, M. (2011). Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis. Annals of the Rheumatic Diseases, 70 (6), 1144-52. doi:10.1136/ard.2010.135541

Conaghan, P. G., D'Agostino, M. A., Le Bars, M., Baron, G., Schmidely, N., Wakefield, R., Ravaud, P., Grassi, W., Martin-Mola, E., So, A., Backhaus, M., Malaise, M., Emery, P., & Dougados, M. (2010). Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study. Annals of the Rheumatic Diseases, 69, 644–647. doi:10.1136/ard.2008.099564

De Bock, M., De Seny, D., Meuwis, M.-A., Chapelle, J.-P., Louis, E., Malaise, M., Merville, M.-P., & Fillet, M. (2009). Challenges for Biomarker Discovery in Body Fluids Using SELDI-TOF-MS. Journal of Biomedicine and Biotechnology. doi:10.1155/2010/906082

De Seny, D., Ribbens, C., Cobraiville, G., Meuwis, M.-A., Marée, R., Geurts, P., Wehenkel, L., Louis, E., Merville, M.-P., Fillet, M., & Malaise, M. (2009). Protéomique par SELDI-TOF-MS des maladies inflammatoires articulaires: identification des protéines S100 comme protéines d'intérêt. Revue Médicale de Liège, 64 (Spec No), 29-35.

Malaise, M. (2009). Synthèse 2009: forger l'avenir. Revue Médicale de Liège, 64 (Spec No), 1.

Relic, B., Zeddou, M., Desoroux, A., Beguin, Y., De Seny, D., & Malaise, M. (2009). Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts. Laboratory Investigation, 89 (7), 811-822. doi:10.1038/labinvest.2009.41

van der Heijde, D., Burmester, G., Melo-Gomes, J., Codreanu, C., Martin Mola, E., Pedersen, R., Robertson, D., Chang, D., Koenig, A., Malaise, M., & Freundlich, B. (2009). Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy. Annals of the Rheumatic Diseases, 68 (7), 1113-1118. doi:10.1136/ard.2008.094375

Von Frenckell, C., & Malaise, M. (2009). Les traitements biologiques en rhumatologie. Revue Médicale de Liège, 64 (5-6), 293-300.

Meuwis, M.-A.* , Fillet, M.* , Lutteri, L., Marée, R., Geurts, P., De Seny, D., Malaise, M., Chapelle, J.-P., Wehenkel, L., Belaiche, J., Merville, M.-P., & Louis, E. (2008). Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study. Clinical Biochemistry, 41 (12), 960-7. doi:10.1016/j.clinbiochem.2008.04.021
* These authors have contributed equally to this work.

Reenaers, C., Franchimont, N., Oury, C., Belaiche, J., Malaise, M., Bours, V., Theatre, E., Delvenne, P., & Louis, E. (2008). Sensitivity of intestinal fibroblasts to TNF-related apoptosis-inducing ligand-mediated apoptosis in Crohn's disease. Scandinavian Journal of Gastroenterology, 43, 1334-1345. doi:10.1080/00365520802200010

Burmester, G. R., Mariette, X., Montecucco, C., Monteagudo-Saez, I., Malaise, M., Tzioufas, A. G., Bijlsma, J. W. J., Unnebrink, K., Kary, S., & Kupper, H. (June 2007). Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial. Annals of the Rheumatic Diseases, 66 (6), 732-739. doi:10.1136/ard.2006.066761

Luyten, F. P., Geusens, P., Malaise, M., De Clerck, L., Westhovens, R., Raeman, F., Vander Mijnsbrugge, D., Mathy, L., Hauzeur, J.-P., De Keyser, F., & Van den Bosch, F. (January 2007). A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip. Annals of the Rheumatic Diseases, 66 (1), 99-106. doi:10.1136/ard.2006.052308

Von Frenckell, C., Henno, A., de LA BRASSINNE, M., & Malaise, M. (2007). Le traitement biologique des maladies inflammatoires à médiation immune. Le cas de la dermatologie et de la rhumatologie. Revue Médicale de Liège, 62 (Spec No), 55-62.

Klareskog, L., Gaubitz, M., Rodriguez-Valverde, V., Malaise, M., Dougados, M., & Wajdula, J. (December 2006). A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs. Annals of the Rheumatic Diseases, 65 (12), 1578-1584. doi:10.1136/ard.2005.038349

Olivier, S., Close, P., Castermans, E., de Leval, L., Tabruyn, S., Chariot, A., Malaise, M., Merville, M.-P., Bours, V., & Franchimont, N. (May 2006). Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature. Molecular Pharmacology, 69 (5), 1615-1623. doi:10.1124/mol.105.020479

Cruyssen, B. V., Van Looy, S., Wyns, B., Westhovens, R., Durez, P., Van den Bosch, F., Mielants, H., De Clerck, L., Peretz, A., Malaise, M., Verbruggen, L., Vastesaeger, N., Geldhof, A., Boullart, L., & De Keyser, F. (2006). Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity. Arthritis Research and Therapy, 8 (4), 112. doi:10.1186/ar2001

Henno, A., Rausin, A., Malaise, M., & De La Brassinne, M. (2006). Psoriasis et arthrite psoriasique. Revue Médicale de Liège, 61 (5-6, May-Jun), 334-340.

D'Agostino, M. A., Conaghan, P., Le Bars, M., Baron, G., Grassi, W., Martin-Mola, E., Wakefield, R., Brasseur, J. L., So, A., Backhaus, M., Malaise, M., Burmester, G., Schmidely, N., Ravaud, P., Dougados, M., & Emery, P. (December 2005). EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: Prevalence of inflammation in osteoarthritis. Annals of the Rheumatic Diseases, 64 (12), 1703-1709. doi:10.1136/ard.2005.037994

Conaghan, P., D'Agostino, M. A., Ravaud, P., Baron, G., Le Bars, M., Grassi, W., Martin-Mola, E., Wakefield, R., Brasseur, J.-L., So, A., Backhaus, M., Malaise, M., Burmester, G., Schmidely, N., Emery, P., & Dougados, M. (2005). EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 2: exploring decision rules for clinical utility. Annals of the Rheumatic Diseases, 64 (12), 1710-1714. doi:10.1136/ard.2005.038026

Cruyssen, B. V., Van Looy, S., Wyns, B., Westhovens, R., Durez, P., Malaise, M., Verbruggen, L., Vastesaeger, N., Geldhof, A., Boullart, L., & De Keyser, F. (2005). DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment. Arthritis Research and Therapy, 7 (5), 1063-R1071. doi:10.1186/ar1787

De Seny, D.* , Fillet, M.* , Meuwis, M.-A., Geurts, P., Lutteri, L., Ribbens, C., Bours, V., Wehenkel, L., Piette, J., Malaise, M., & Merville, M.-P. (2005). Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis and Rheumatism, 52 (12), 3801-12. doi:10.1002/art.21607
* These authors have contributed equally to this work.

Geurts, P., Fillet, M., De Seny, D., Meuwis, M.-A., Malaise, M., Merville, M.-P., & Wehenkel, L. (2005). Proteomic mass spectra classification using decision tree based ensemble methods. Bioinformatics, 21 (14), 3138-45. doi:10.1093/bioinformatics/bti494

Olivier, S., Fillet, M., Malaise, M., Piette, J., Bours, V., Merville, M.-P., & Franchimont, N. (2005). Sodium nitroprusside-induced osteoblast apoptosis is mediated by long chain ceramide and is decreased by raloxifene. Biochemical Pharmacology, 69 (6), 891-901. doi:10.1016/j.bcp.2004.11.030

Franchimont, N., Reenaers, C., Lambert, C., Belaiche, J., Bours, V., Malaise, M., Delvenne, P., & Louis, E. (December 2004). Increased expression of receptor activator of NF-kappa B ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clinical and Experimental Immunology, 138 (3), 491-498. doi:10.1111/j.1365-2249.2004.02643.x

Franchimont, N., Putzeys, V., Collette, J., Vermeire, S., Rutgeerts, P., De Vos, M., Van Gossum, A., Franchimont, D., Fiasse, R., Pelckmans, P., Malaise, M., Belaiche, J., & Louis, E. (15 September 2004). Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Alimentary Pharmacology and Therapeutics, 20 (6), 607-614. doi:10.1111/j.1365-2036.2004.02152.x

Kirwan, J. R., Hallgren, R., Mielants, H., Wollheim, F., Bjorck, E., Persson, T., Book, C., Bowman, S., Byron, M., Cox, N., Field, M., Kanerud, L., Leirisalo-Repo, M., Malaise, M., Mohammad, A., Palmer, R., Petersson, I. F., Ringertz, B., Sheldon, P., ... Van den Bosch, F. (June 2004). A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis. Annals of the Rheumatic Diseases, 63 (6), 688-695. doi:10.1136/ard.2003.008573

van de Putte, B. A., Atkins, C., Malaise, M., Sany, J., Russell, A. S., van Riel, P. L. C. M., Settas, L., Biljsma, J. W., Todesco, S., Dougados, M., Nash, P., Emery, P., Walter, N., Kaul, M., Fischkoff, S., & Kupper, H. (01 May 2004). Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Annals of the Rheumatic Diseases, 63 (5), 508-516. doi:10.1136/ard.2003.013052

Leclercq, P., Hermesse, A., & Malaise, M. (2004). Fièvre méditerranéenne familiale. Revue Médicale de Liège, 59 (5), 320-325.

Leclercq, P., & Malaise, M. (2004). Le medicament du mois. Etoricoxib (Arcoxia). Revue Médicale de Liège, 59 (5), 345-349.

Leclercq, P., & Malaise, M. (2004). La goutte. Revue Médicale de Liège, 59 (5), 274-280.

Scheen, A., & Malaise, M. (2004). Le medicament du mois. Valdecoxib (Bextra). Revue Médicale de Liège, 59 (4), 251-254.

van de Putte, L. B. A., Rau, R., Breedveld, F. C., Kalden, J. R., Malaise, M., van Riel, P. L. C. M., Schattenkirchner, M., Emery, P., Burmester, G. R., Zeidler, H., Moutsopoulos, H. M., Beck, K., & Kupper, H. (2003). Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study. Annals of the Rheumatic Diseases, 62 (12), 1168-1177. doi:10.1136/ard.2003.009563

Louis, E., Vermeire, S., Rutgeerts, P., De Vos, M., Van Gossum, A., Pescatore, P., Fiasse, R., Pelckmans, P., Reynaert, H., D'Haens, G., Malaise, M., & Belaiche, J. (July 2002). A positive response to infliximab in Crohn disease: Association with a higher systemic inflammation before treatment but not with-308 TNF gene polymorphism. Scandinavian Journal of Gastroenterology, 37 (7), 818-824. doi:10.1080/713786515

BECKERS, C., Foidart, J., Thiry, A., & Malaise, M. (2002). Métastase synoviale d'un cancer colique se présentant comme une arthrite du genou. Caractérisation par tomographie à émission de positons au 18FDG. Revue Médicale de Liège, 57 (5), 467-474.

Belhocine, T., Kaye, O., Delanaye, P., Corman, V., Baghaie, M., Deprez, M., Daenen, F., De Barsy, C., Beckers, C., Gomez, P., Hustinx, R., Foidart-Willems, J., Demonty, J., Malaise, M., & Rigo, P. (2002). Maladie de Horton et atteintes arterielles extratemporales: utilite de la tomographie par emission de positons au 18FDG. A propos de trois observations et d'une revue de la litterature. Revue de Médecine Interne, 23 (7), 584-91. doi:10.1016/S0248-8663(02)00620-3

Kaiser, M.-J., & Malaise, M. (2002). Déminéralisation et ostéoporose: une confusion sémantique. Revue Médicale de Liège, 57 (5), 274-279.

Kaiser, M.-J., & Malaise, M. (2002). Comment je traite ... une polyarthrite rhumatoïde. L'avènement d'une nouvelle ère thérapeutique: les anticorps anti-TNF-alpha. Revue Médicale de Liège, 57 (8), 486-492.

Malaise, M., Kaye, O., Radermecker, M., Duysinx, B., Hustinx, R., Hermans, G., & de Leval, L. (2002). Une dorsalgie malheureusement tenace. Revue Médicale de Liège, 57 (5), 270-273.

Ribbens, C., Martin y Porras, M., Franchimont, N., Kaiser, M.-J., Jaspar, J. M., Damas, P., Houssiau, F. A., & Malaise, M. (2002). Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Annals of the Rheumatic Diseases, 61 (2), 161-166. doi:10.1136/ard.61.2.161

Denis, M. A., Louis, R., Malaise, M., Belaiche, J., & Louis, E. (February 2001). Increased Response of Blood Eosinophils to Various Chemotactic Agents in Quiescent Crohn Disease. Scandinavian Journal of Gastroenterology, 36 (2), 190-5. doi:10.1080/003655201750065951

BECKERS, C., HUSTINX, R., FOIDART-WILLEMS, J., RIGO, P., & MALAISE, M. (2001). Glucose metabolism in rheumatoid arthritis knee joints before and after anti-TNF-apha blockade : evaluation by PET with 18-FDG. IN PROCEEDINGS ANNUAL AMI MEETING 2001, P56.

Bettiol, J., Bartsch, P., Louis, R., De Groote, D., Gevaerts, Y., Louis, E., & Malaise, M. (December 2000). Cytokine Production from Peripheral Whole Blood in Atopic and Nonatopic Asthmatics: Relationship with Blood and Sputum Eosinophilia and Serum Ige Levels. Allergy, 55 (12), 1134-41. doi:10.1034/j.1398-9995.2000.00711.x

Malaise, M. (2000). Les non-recommandations dans le traitement de l'arthrose et de la polyarthrite rhumatoïde, ou pourquoi la médecine basée sur le niveau de preuve ne s'applique pas (encore) à la rhumatologie. Revue Médicale de Liège, 55 (5), 466-475.

Andre, B., Ribbens, C., Kaye, O., & Malaise, M. (April 1997). Les manifestations osteo-articulaires du sujet âgé. Revue Médicale de Liège, 52 (4), 270-277.

Kaye, O., Ribbens, C., Kahn, M. F., & Malaise, M. (1997). Sarcoidosis: recognition and treatment guidelines. BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 7 (6), 441-447. doi:10.2165/00063030-199707060-00003

Malaise, M. (January 1996). Les anti-inflammatoires non stéroïdiens. Revue Médicale de Liège, 51 (1), 123-125.

Kaye, O., Ribbens, C., Hauwaert, C., & Malaise, M. (1995). Le méthotrexate en rhumatologie: une révolution thérapeutique. Revue Médicale de Liège, 50 (11), 453-457.

Malaise, M. (1991). Phagocytose immune et non immune. Revue Médicale de Liège, 46 (9), 486-503.

Mahieu, P., Malaise, M., Hoyoux, C., & Davin, J. C. (1988). Influence de la grossesse sur certaines maladies auto-immunes. Revue Médicale de Liège, 43 (22), 727-736.

Mahieu, P., Davin, J. C., & Malaise, M. (1987). Intérêts diagnostiques et thérapeutique des anticorps monoclonaux en néphrologie. Revue Médicale de Liège, 42 (10), 470-474.

Malaise, M., Lust, C., Foidart, J. B., & Mahieu, P. (1985). Complement activation during hemodialysis [letter to the editor]. New England Journal of Medicine, 312 (8), 514-515. doi:10.1056/NEJM198502213120813

Malaise, M., & Mahieu, P. R. (1985). The Fc-receptor function of human mononuclear phagocyte system: physiological role, alteration in immune diseases and modulation. Acta Clinica Belgica, 40 (1), 27-37. doi:10.1080/22953337.1985.11719047

Malaise, M., & Mahieu, P. (1985). Bilan minimum d'orientation dans le diagnostic immunologique. Revue Médicale de Liège, 40 (8), 288-301.